/

City Therapeutics

Developing next-generation RNA interference-based medicines for various diseases.

BiotechnologyPharmaceuticals citytx.com ↗

Company facts

Founded: 2024
Employees: 72
Headquarters: United States
Type: Private
Funding: Series A · $135M · 2024